High Purity Pregabalin CAS 148553-50-8 - China Suppliers & Factory with Safe Delivery
Tetracaine Specification
Pregabalin is a second- generation antiepileptic drug (AED) known with the proprietary brand name of Lyrica® (Pfizer, Tadworth) in the UK and USA (Pfizer, New York, NY).
Pregabalin (Lyrica), a derivative of GABA that is closely related to gabapentin, has undergone extensive research for its efficacy in treating conditions such as generalized anxiety disorder (GAD), fibromyalgia, neuropathic pain, and partial complex seizures. It seems to have a more targeted effect on the a2-δ subunit of calcium channels in the brain compared to gabapentin. Pregabalin was granted FDA approval at the end of 2004 for the treatment of neuropathic pain and epilepsy. In 2008, it became the first medication approved for the management of fibromyalgia. Although pregabalin was approved for GAD treatment in the European Union in 2006, it has not yet received FDA approval for GAD in the United States as of the time of writing.
Pregabalin, marketed as the anticonvulsant drug Lyrica, is used in the treatment of epilepsy and generalized anxiety disorder. Along with other anticonvulsants such as gabapentin and levetiracetam, pregabalin is also used to treat neuropathic pain. This certified reference standard is suitable for pregabalin GC/MS or LC/MS applications from forensic analysis, clinical toxicology and pain prescription monitoring to urine drug testing.
TETRACAINE HCL APPLICATIONS
S-Enantiomer of Pregabalin. A GABA analogue used as an anticonvulsant. Anxiolytic analgesic used to treat peripheral neuropathic pain and fibromyalgia.
Pregabalin is an anticonvulsant drug used for neuropathic pain, as an adjunct therapy for partial seizures, and in generalized anxiety disorder. It was designed as a more potent successor to gabapentin.
Pregabalin is used to treat epilepsy and anxiety. It’s also taken to treat nerve pain. Nerve pain can be caused by different conditions including diabetes and shingles, or an injury.
details
Frequently Asked Questions
What is Pregabalin and what is its proprietary brand name?
Pregabalin is a second-generation antiepileptic drug (AED) widely recognized by the proprietary brand name Lyrica®.
What medical conditions are treated using Pregabalin?
Pregabalin is primarily used to treat epilepsy, generalized anxiety disorder (GAD), fibromyalgia, neuropathic pain (nerve pain caused by conditions like diabetes, shingles, or injury), and partial complex seizures.
How does Pregabalin compare to Gabapentin?
Pregabalin is a GABA analogue designed as a more potent successor to gabapentin. It exhibits a more targeted effect on the a2-δ subunit of calcium channels in the brain.
When did Pregabalin receive FDA approval?
Pregabalin received FDA approval at the end of 2004 for treating neuropathic pain and epilepsy, and later in 2008 as the first approved medication for fibromyalgia management.
What are the analytical applications of the certified reference standard?
The certified reference standard is suitable for GC/MS or LC/MS applications, including forensic analysis, clinical toxicology, pain prescription monitoring, and urine drug testing.





